MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-09-12
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00001121
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Howard Brown Health Ctr / HIVNET, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Fenway Community Health Ctr / HIVNET, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Miriam Hosp, Providence, Rhode Island, United States

and more 8 locations

Identifying Emergency Room Patients Who Have Recently Been Infected With HIV

Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-09-09
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
200
Registration Number
NCT00001130
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSD, San Diego, California, United States

HIV Prevention Counseling for Men Who Have Sex With Men

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-09-09
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
4350
Registration Number
NCT00000931
Locations
๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Dept of Hlth / AIDS Office, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Denver Dept of Public Health / HIVNET, Denver, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

New York Blood Ctr, Bronx, New York, United States

and more 3 locations

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-09-09
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
28
Registration Number
NCT00000795
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Univ / Ctr for Immunological Research, Baltimore, Maryland, United States

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Phase 1
Completed
Conditions
HIV Infections
Tuberculosis
First Posted Date
2001-08-31
Last Posted Date
2008-09-11
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
44
Registration Number
NCT00004736
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of California / San Diego Treatment Ctr, San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States

and more 7 locations

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-09-09
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
80
Registration Number
NCT00001132
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of Miami School of Medicine, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Emory Univ, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cook County Hosp, Chicago, Illinois, United States

and more 27 locations

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-08-26
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
20
Registration Number
NCT00000699
Locations
๐Ÿ‡บ๐Ÿ‡ธ

George Washington Univ Med Ctr, Washington, District of Columbia, United States

A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT

Phase 1
Terminated
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-08-26
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
35
Registration Number
NCT00000686
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cornell Univ Med Ctr, New York, New York, United States

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-08-26
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
25
Registration Number
NCT00000669
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of Miami School of Medicine, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Regional Medical Ctr, Memphis, Memphis, Tennessee, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ TX Health Science Ctr, Houston, Texas, United States

and more 2 locations

A Study of BMY-27857 in Patients With AIDS or AIDS Related Complex

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2008-08-26
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
40
Registration Number
NCT00000988
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mount Sinai Med Ctr, New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cornell Univ Med Ctr, New York, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath